Stockreport

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K [Yahoo! Finance]

BioRestorative Therapies, Inc.  (BRTX) 
NASDAQ:AMEX Investor Relations: biorestorative.com/content/investor-relations
PDF clinical stage company focused on stem cell-based therapies, announced today the filing of its Form 10-K annual report with the Securities and Exchange Commission ("SEC" [Read more]